Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LEVO C3

K-Number: K083017 · 2008-10-24

ApplicantLevo AG
Decision Date2008-10-24
Product CodeIPL
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

LEVO C3 is the device name listed in this FDA 510(k) record. The listed applicant is Levo AG. It received FDA 510(k) clearance on 2008-10-24 under 510(k) number K083017. The device is classified under product code IPL. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LEVO C3?

LEVO C3 is a medical device that received FDA 510(k) clearance on 2008-10-24. The listed applicant is Levo AG. The 510(k) number is K083017.

When did LEVO C3 receive FDA 510(k) clearance?

LEVO C3 received FDA 510(k) clearance on 2008-10-24, under 510(k) number K083017.

Who is the listed applicant for LEVO C3?

The FDA 510(k) record lists Levo AG as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LEVO C3?

The FDA product code for LEVO C3 is IPL.

Other records listing Levo AG as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: IPL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑